ストックスクリーナーアプリを入手
3.755
8.86%
-0.365
前日終値:
$4.12
開ける：
$4.01
24時間の取引高:
896.34K
Relative Volume:
0.23
時価総額：
$42.84M
収益：
$32.77M
当期純損益:
$-101.98M
株価収益率:
-0.3907
EPS:
-9.6101
ネットキャッシュフロー:
$-112.43M
1週間 パフォーマンス:
-4.21%
1か月 パフォーマンス:
+95.06%
6か月 パフォーマンス:
-66.13%
1年 パフォーマンス:
-81.93%
1日の値動き範囲:
$3.70
$4.09
1週間の範囲:
$3.57
$4.83
52週間の値動き範囲:
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
名前
X 4 Pharmaceuticals Inc
セクター
電話
857-529-8300
住所
61 NORTH BEACON STREET, BOSTON, MA
XFOR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
3.755 | 92.49M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-12 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 再開されました | B. Riley Securities | Buy |
| 2022-12-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 開始されました | Piper Sandler | Overweight |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2019-12-18 | 開始されました | ROTH Capital | Buy |
| 2019-12-09 | アップグレード | Citigroup | Neutral → Buy |
| 2019-12-05 | 開始されました | B. Riley FBR | Buy |
| 2019-06-07 | 開始されました | Stifel | Buy |
| 2019-06-05 | 開始されました | Cowen | Outperform |
すべてを表示
X 4 Pharmaceuticals Inc (XFOR) 最新ニュース
Will X4 Pharmaceuticals Inc. continue its uptrend2025 Top Decliners & AI Driven Stock Reports - Newser
Trend analysis for X4 Pharmaceuticals Inc. this weekRecession Risk & Low Risk Entry Point Tips - Newser
Is X4 Pharmaceuticals Inc. stock entering bullish territoryNew Guidance & Long-Term Safe Investment Plans - Newser
Is X4 Pharmaceuticals Inc. trending in predictive chart modelsAnalyst Downgrade & Community Verified Watchlist Alerts - Newser
Published on: 2025-08-31 02:01:17 - Newser
Applying chart zones and confluence areas to X4 Pharmaceuticals Inc.Market Movers & Consistent Growth Equity Picks - Newser
Stifel Nicolaus Issues Pessimistic Forecast for X4 Pharmaceuticals (NASDAQ:XFOR) Stock Price - Defense World
Will X4 Pharmaceuticals Inc. outperform the market2025 Year in Review & Verified Chart Pattern Signals - Newser
X4 Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
How to recover losses in X4 Pharmaceuticals Inc. stockMarket Activity Report & Weekly Breakout Stock Alerts - Newser
Price momentum metrics for X4 Pharmaceuticals Inc. explainedMarket Sentiment Report & Long-Term Safe Investment Plans - Newser
Multi asset correlation models including X4 Pharmaceuticals Inc.Options Play & Real-Time Volume Trigger Notifications - Newser
What are the analyst revisions for X4 Pharmaceuticals Inc.Is AMCX stock a good investment in YEAR - sundaytimes.kr
What to expect from X4 Pharmaceuticals Inc. in the next 30 daysQuarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Real time breakdown of X4 Pharmaceuticals Inc. stock performanceMarket Activity Report & Real-Time Stock Price Movement Reports - Newser
Using data tools to time your X4 Pharmaceuticals Inc. exit2025 Dividend Review & Short-Term High Return Ideas - Newser
X4 Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Action & Weekly Return Optimization Alerts - Newser
Published on: 2025-08-30 12:12:45 - Newser
What analysts say about X4 Pharmaceuticals Inc. stock outlookWeekly Stock Recap & Weekly High Conviction Trade Ideas - Newser
Will X4 Pharmaceuticals Inc. benefit from macro trendsMarket Rally & Consistent Growth Equity Picks - Newser
Forecasting X4 Pharmaceuticals Inc. price range with options dataWall Street Watch & Expert Curated Trade Setups - Newser
Does X4 Pharmaceuticals Inc. qualify in momentum factor screeningFed Meeting & High Accuracy Swing Entry Alerts - Newser
Can X4 Pharmaceuticals Inc. Regain Lost Ground This Quarter getLinesFromResByArray error: size == 0 - sisain.net
Using R and stats models for X4 Pharmaceuticals Inc. forecastingMarket Volume Report & Stock Timing and Entry Methods - Newser
X4 Pharmaceuticals Inc. Stock Flags Risk Zone in Volatility Index getLinesFromResByArray error: size == 0 - classian.co.kr
X4 Pharmaceuticals Inc.’s volatility index tracking explained2025 Key Lessons & Weekly Top Gainers Trade List - Newser
X 4 Pharmaceuticals Inc (XFOR) 財務データ
収益
当期純利益
現金流量
EPS
X 4 Pharmaceuticals Inc (XFOR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Baldry Mark | Chief Commercial Officer |
Nov 15 '24 |
Buy |
0.34 |
13,404 |
4,598 |
129,173 |
| Ragan Paula | President and CEO |
Jan 24 '25 |
Sale |
0.45 |
76,473 |
34,719 |
1,087,386 |
| Mostafa Adam S. | Chief Financial Officer |
Jan 24 '25 |
Sale |
0.45 |
74,773 |
33,947 |
0 |
| Baldry Mark | Chief Commercial Officer |
Jan 24 '25 |
Sale |
0.45 |
29,159 |
13,241 |
94,123 |
| DiBiase Mary | Chief Operating Officer |
Jan 24 '25 |
Sale |
0.45 |
22,258 |
10,094 |
490,980 |
| Arbet-Engels Christophe | Chief Medical Officer |
Jan 24 '25 |
Sale |
0.45 |
11,624 |
5,284 |
14,207 |
0.96%
1.09%
大文字化:
|
ボリューム (24 時間):